ClinicalTrials.govpublic full text
A Phase Ⅰ/Ⅱa Clinical Study of GEN-725 in Combination With Dositinib
non-small cell lung cancer, egfr mutation, gen -725, dositinib, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 811539
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.